Nicolas Janus

2.5k total citations
70 papers, 1.7k citations indexed

About

Nicolas Janus is a scholar working on Pulmonary and Respiratory Medicine, Pediatrics, Perinatology and Child Health and Pathology and Forensic Medicine. According to data from OpenAlex, Nicolas Janus has authored 70 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Pulmonary and Respiratory Medicine, 20 papers in Pediatrics, Perinatology and Child Health and 15 papers in Pathology and Forensic Medicine. Recurrent topics in Nicolas Janus's work include Pharmacological Effects and Toxicity Studies (20 papers), Renal cell carcinoma treatment (15 papers) and Chemotherapy-induced organ toxicity mitigation (15 papers). Nicolas Janus is often cited by papers focused on Pharmacological Effects and Toxicity Studies (20 papers), Renal cell carcinoma treatment (15 papers) and Chemotherapy-induced organ toxicity mitigation (15 papers). Nicolas Janus collaborates with scholars based in France, Belgium and United States. Nicolas Janus's co-authors include Vincent Launay‐Vacher, Gilbert Deray, Stéphane Oudard, Joseph Gligorov, Jean‐François Morère, Philippe Beuzeboc, Xavier Pourrat, Olivier Rixe, Juliette Thariat and Gilbert Deray and has published in prestigious journals such as Nucleic Acids Research, Journal of Clinical Oncology and Blood.

In The Last Decade

Nicolas Janus

64 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nicolas Janus France 20 476 372 357 269 268 70 1.7k
Hassan Izzedine France 27 738 1.6× 530 1.4× 559 1.6× 410 1.5× 271 1.0× 94 2.1k
Georges Saab United States 19 312 0.7× 93 0.3× 730 2.0× 170 0.6× 194 0.7× 41 1.5k
Marco Quaglia Italy 23 375 0.8× 168 0.5× 472 1.3× 333 1.2× 211 0.8× 96 1.8k
Meghan E. Sise United States 32 566 1.2× 727 2.0× 1.2k 3.2× 203 0.8× 126 0.5× 133 3.7k
Ranjan Pathak United States 20 317 0.7× 408 1.1× 82 0.2× 134 0.5× 157 0.6× 107 1.5k
Hanny Al‐Samkari United States 31 579 1.2× 461 1.2× 72 0.2× 275 1.0× 203 0.8× 193 3.8k
Patricia Stewart United States 36 572 1.2× 978 2.6× 132 0.4× 364 1.4× 225 0.8× 81 4.1k
Richard Fatica United States 23 484 1.0× 237 0.6× 398 1.1× 183 0.7× 52 0.2× 41 1.6k
John W. Gyves United States 23 496 1.0× 460 1.2× 72 0.2× 292 1.1× 69 0.3× 31 1.7k
Simon Knight United Kingdom 30 905 1.9× 362 1.0× 148 0.4× 188 0.7× 69 0.3× 118 3.0k

Countries citing papers authored by Nicolas Janus

Since Specialization
Citations

This map shows the geographic impact of Nicolas Janus's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicolas Janus with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicolas Janus more than expected).

Fields of papers citing papers by Nicolas Janus

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nicolas Janus. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicolas Janus. The network helps show where Nicolas Janus may publish in the future.

Co-authorship network of co-authors of Nicolas Janus

This figure shows the co-authorship network connecting the top 25 collaborators of Nicolas Janus. A scholar is included among the top collaborators of Nicolas Janus based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nicolas Janus. Nicolas Janus is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Janus, Nicolas, et al.. (2023). How to manage the dose of drugs in cancer patients with acute kidney injury, practical recommendations. International Journal of Clinical Pharmacy. 46(1). 210–213. 2 indexed citations
2.
Frère, Corinne, Carme Font, F. Espósito, et al.. (2021). Incidence, risk factors, and management of bleeding in patients receiving anticoagulants for the treatment of cancer-associated thrombosis. Supportive Care in Cancer. 30(4). 2919–2931. 13 indexed citations
3.
Tazi, Illias, et al.. (2017). Is Tenofovir Alafenamide Safer than Tenofovir Disoproxil Fumarate for the Kidneys?. PubMed. 18(4). 184–192. 20 indexed citations
4.
Babiceanu, Mihaela, Fujun Qin, Zhongqiu Xie, et al.. (2016). Recurrent chimeric fusion RNAs in non-cancer tissues and cells. Nucleic Acids Research. 44(6). 2859–2872. 124 indexed citations
5.
Launay‐Vacher, Vincent, Nicolas Janus, & Gilbert Deray. (2016). Renal insufficiency and cancer treatments. ESMO Open. 1(4). e000091–e000091. 54 indexed citations
6.
Janus, Nicolas, et al.. (2016). Renal function and venous thromboembolic diseases. Journal des Maladies Vasculaires. 41(6). 389–395. 5 indexed citations
7.
Janus, Nicolas, Jean-Pierre Laroche, Isabelle Mahé, & Vincent Launay‐Vacher. (2015). Maladie thromboembolique veineuse : faut-il encore évaluer la fonction rénale du patient avant un traitement anticoagulant ?. Journal de Pharmacie Clinique. 34(2). 57–65. 1 indexed citations
8.
Janus, Nicolas, et al.. (2014). Adaptation posologique chez les patients insuffisants rénaux chroniques et évaluation de la fonction rénale : focus sur les patients de cardiologie. Annales de Cardiologie et d Angéiologie. 64(1). 1–8. 3 indexed citations
9.
Janus, Nicolas, Vincent Launay‐Vacher, Gilbert Deray, A. Thyss, & Juliette Thariat. (2012). Gestion des chimiothérapies chez les patients hémodialysés. Bulletin du Cancer. 99(3). 371–380. 7 indexed citations
10.
Janus, Nicolas, Vincent Launay‐Vacher, A. Thyss, et al.. (2012). Management of anticancer treatment in patients under chronic dialysis: results of the multicentric CANDY (CANcer and DialYsis) study. Annals of Oncology. 24(2). 501–507. 54 indexed citations
11.
Thariat, Juliette, Nicolas Janus, Jérôme Barrière, & Vincent Launay‐Vacher. (2012). Tolérance rénale des thérapies ciblées. Bulletin du Cancer. 99(3). 317–322. 3 indexed citations
12.
Rey, Jean‐Baptiste, et al.. (2012). Gestion des antalgiques chez les patients insuffisants rénaux en cancérologie. Bulletin du Cancer. 99(3). 345–369.
13.
Janus, Nicolas & Vincent Launay‐Vacher. (2011). Complication de l’insuffisance rénale chronique : l’anémie et ses traitements. Journal de Pharmacie Clinique. 30(4). 229–234. 2 indexed citations
14.
Janus, Nicolas, Vincent Launay‐Vacher, J-P. Machiels, et al.. (2010). Cancer and renal insufficiency results of the BIRMA study. British Journal of Cancer. 103(12). 1815–1821. 133 indexed citations
15.
Janus, Nicolas, et al.. (2010). Vaccination et insuffisance rénale chronique. Journal de Pharmacie Clinique. 29(3). 149–157.
16.
Karie, Svetlana, et al.. (2009). Renal Safety of Gadolinium-based Contrast Media in Patients with Chronic Renal Insufficiency. Radiology. 250(3). 618–628. 107 indexed citations
17.
Janus, Nicolas, Vincent Launay‐Vacher, Svetlana Karie, et al.. (2009). Prevalence of nephrogenic systemic fibrosis in renal insufficiency patients: Results of the FINEST study. European Journal of Radiology. 73(2). 357–359. 37 indexed citations
18.
Launay‐Vacher, Vincent, Joseph Gligorov, Christophe Le Tourneau, et al.. (2008). Prevalence of renal insufficiency in breast cancer patients and related pharmacological issues. Breast Cancer Research and Treatment. 124(3). 745–753. 43 indexed citations
19.
Launay‐Vacher, Vincent, Jean‐Philippe Spano, Nicolas Janus, et al.. (2008). Renal insufficiency and anticancer drugs in elderly cancer patients: A subgroup analysis of the IRMA study. Critical Reviews in Oncology/Hematology. 70(2). 124–133. 40 indexed citations
20.
Karie, S., Frédérique Gandjbakhch, Nicolas Janus, et al.. (2007). Kidney disease in RA patients: prevalence and implication on RA-related drugs management: the MATRIX study. Lara D. Veeken. 47(3). 350–354. 79 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hassan Izzedine Breakdown of academic impact, for papers by Georges Saab Breakdown of academic impact, for papers by Marco Quaglia Breakdown of academic impact, for papers by Meghan E. Sise Breakdown of academic impact, for papers by Ranjan Pathak Breakdown of academic impact, for papers by Hanny Al‐Samkari Breakdown of academic impact, for papers by Patricia Stewart Breakdown of academic impact, for papers by Richard Fatica Breakdown of academic impact, for papers by John W. Gyves Breakdown of academic impact, for papers by Simon Knight
Rankless by CCL
2026